Peter K. Tothy

670 total citations
7 papers, 464 citations indexed

About

Peter K. Tothy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine. According to data from OpenAlex, Peter K. Tothy has authored 7 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Complementary and alternative medicine. Recurrent topics in Peter K. Tothy's work include Lung Cancer Diagnosis and Treatment (2 papers), Complementary and Alternative Medicine Studies (2 papers) and Lung Cancer Research Studies (2 papers). Peter K. Tothy is often cited by papers focused on Lung Cancer Diagnosis and Treatment (2 papers), Complementary and Alternative Medicine Studies (2 papers) and Lung Cancer Research Studies (2 papers). Peter K. Tothy collaborates with scholars based in United States. Peter K. Tothy's co-authors include Charlotte Gyllenhaal, Keith I. Block, Amanda Koch, Mark N. Mead, Robert A. Newman, Hedy L. Kindler, Richard McCormack, Sridhar Mani, Everett E. Vokes and Robert A. Wolff and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Cancer Treatment Reviews.

In The Last Decade

Peter K. Tothy

7 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter K. Tothy United States 5 167 102 82 69 58 7 464
Annie Turkieh France 11 307 1.8× 57 0.6× 48 0.6× 51 0.7× 55 0.9× 22 713
Attila Czompa Hungary 12 179 1.1× 39 0.4× 45 0.5× 65 0.9× 72 1.2× 16 466
Mingxi Tang China 14 280 1.7× 79 0.8× 67 0.8× 87 1.3× 40 0.7× 34 623
Stéphanie Delemasure France 17 332 2.0× 68 0.7× 36 0.4× 66 1.0× 69 1.2× 39 727
Duen S. Chou Taiwan 9 156 0.9× 41 0.4× 39 0.5× 84 1.2× 28 0.5× 12 522
Kirtikar Shukla United States 16 211 1.3× 61 0.6× 26 0.3× 43 0.6× 53 0.9× 29 570
Guozhu Han China 13 294 1.8× 34 0.3× 33 0.4× 42 0.6× 60 1.0× 33 610
Zorica Arsova‐Sarafinovska North Macedonia 10 283 1.7× 132 1.3× 27 0.3× 84 1.2× 47 0.8× 32 623
Mona F. El-Azab Egypt 18 306 1.8× 50 0.5× 79 1.0× 20 0.3× 58 1.0× 37 790
Yawei Xu China 8 277 1.7× 47 0.5× 41 0.5× 38 0.6× 23 0.4× 20 615

Countries citing papers authored by Peter K. Tothy

Since Specialization
Citations

This map shows the geographic impact of Peter K. Tothy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Tothy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Tothy more than expected).

Fields of papers citing papers by Peter K. Tothy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Tothy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Tothy. The network helps show where Peter K. Tothy may publish in the future.

Co-authorship network of co-authors of Peter K. Tothy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Tothy. A scholar is included among the top collaborators of Peter K. Tothy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Tothy. Peter K. Tothy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Jean‐Pierre, Pascal, et al.. (2015). Pilot examination of functional Near-Infrared spectroscopy (fNIRS) to quantify chemobrain.. Journal of Clinical Oncology. 33(15_suppl). e20680–e20680. 1 indexed citations
2.
Block, Keith I., et al.. (2009). Making Circadian Cancer Therapy Practical. Integrative Cancer Therapies. 8(4). 371–386. 12 indexed citations
3.
Block, Keith I., Amanda Koch, Mark N. Mead, et al.. (2008). Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials. International Journal of Cancer. 123(6). 1227–1239. 237 indexed citations
4.
Choong, Nicholas W., Everett E. Vokes, Daniel J. Haraf, et al.. (2008). Phase I Study of Induction Chemotherapy and Concomitant Chemoradiotherapy with Irinotecan, Carboplatin, and Paclitaxel for Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(1). 59–67. 5 indexed citations
5.
Block, Keith I., Amanda Koch, Mark N. Mead, et al.. (2007). Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Cancer Treatment Reviews. 33(5). 407–418. 161 indexed citations
6.
Kindler, Hedy L., Peter K. Tothy, Robert A. Wolff, et al.. (2005). Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers. Investigational New Drugs. 23(5). 489–493. 47 indexed citations
7.
Tothy, Peter K., Ann M. Mauer, D. Haraf, et al.. (2004). A phase I study of induction chemotherapy (CT) and concomitant chemoradiotherapy (CRT) with carboplatin (C), paclitaxel (P), and irinotecan (I) for stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7170–7170. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annie Turkieh Breakdown of academic impact, for papers by Attila Czompa Breakdown of academic impact, for papers by Mingxi Tang Breakdown of academic impact, for papers by Stéphanie Delemasure Breakdown of academic impact, for papers by Duen S. Chou Breakdown of academic impact, for papers by Kirtikar Shukla Breakdown of academic impact, for papers by Guozhu Han Breakdown of academic impact, for papers by Zorica Arsova‐Sarafinovska Breakdown of academic impact, for papers by Mona F. El-Azab Breakdown of academic impact, for papers by Yawei Xu
Rankless by CCL
2026